{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:40:09Z","timestamp":1790419209009,"version":"4.1.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.clinbiochem.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T20:44:12Z","timestamp":1606250652000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Effects of fetuin-A with diverse functions and multiple mechanisms on human health"],"prefix":"10.1016","volume":"88","author":[{"given":"Mehmet Arif","family":"Icer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Y\u0131ld\u0131ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clinbiochem.2020.11.004_b0005","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3390\/jcm8122033","article-title":"Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: a concise review","volume":"8","author":"Bourebaba","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein \u03b1 2\u2013Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Sch\u00e4fer","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0015","series-title":"Seminars in dialysis: 2007","first-page":"113","article-title":"Vascular calcification in patients with kidney disease: inhibitors of calcification in blood and urine","author":"Schlieper","year":"2007"},{"issue":"49","key":"10.1016\/j.clinbiochem.2020.11.004_b0020","doi-asserted-by":"crossref","first-page":"31735","DOI":"10.1074\/jbc.271.49.31735","article-title":"Limited proteolysis of human \u03b12-HS glycoprotein\/fetuin vidence that a chymotryptic activity can release the connecting peptide","volume":"271","author":"Nawratil","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tcm.2007.02.005","article-title":"Vascular calcification and fetuin-A deficiency in chronic kidney disease","volume":"17","author":"Westenfeld","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12944-019-1021-8","article-title":"Fetuin-A is also an adipokine","volume":"18","author":"Jialal","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0035","first-page":"1","article-title":"Effects of nutritional status on serum fetuin-A level","author":"Icer","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001765","article-title":"Fetuin-A induces cytokine expression and suppresses adiponectin production","volume":"3","author":"Hennige","year":"2008","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/0008-5472.499.65.2","article-title":"The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms","volume":"65","author":"Kundranda","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellsig.2017.10.005","article-title":"Impairment of energy sensors, SIRT1 and AMPK, in lipid induced inflamed adipocyte is regulated by Fetuin A","volume":"42","author":"Chattopadhyay","year":"2018","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228503","article-title":"Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity","volume":"15","author":"Herrmann","year":"2020","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00240-013-0613-4","article-title":"Patients with nephrolithiasis had lower fetuin-A protein level in urine and renal tissue","volume":"42","author":"Wu","year":"2014","journal-title":"Urolithiasis"},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2019.11.015","article-title":"Epicardial adipose tissue volume and annexin A2\/fetuin-A signalling are linked to coronary calcification in advanced coronary artery disease: Computed tomography and proteomic biomarkers from the EPICHEART study","volume":"292","author":"Mancio","year":"2020","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019228","article-title":"Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults","volume":"6","author":"Song","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2006.09.071","article-title":"Fetuin-null mice are protected against obesity and insulin resistance associated with aging","volume":"350","author":"Mathews","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.clinbiochem.2020.11.004_b0080","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.febslet.2012.07.071","article-title":"Fetuin-A triggers the secretion of a novel set of exosomes in detached tumor cells that mediate their adhesion and spreading","volume":"586","author":"Watson","year":"2012","journal-title":"FEBS Lett."},{"issue":"3914","key":"10.1016\/j.clinbiochem.2020.11.004_b0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/154575a0","article-title":"Fetuin, a new globulin isolated from serum","volume":"154","author":"Pedersen","year":"1944","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00223-012-9690-6","article-title":"The role of fetuin-A in physiological and pathological mineralization","volume":"93","author":"Brylka","year":"2013","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12020-016-1132-1","article-title":"Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity","volume":"55","author":"P\u00e9rez-Sotelo","year":"2017","journal-title":"Endocrine"},{"issue":"39","key":"10.1016\/j.clinbiochem.2020.11.004_b0100","doi-asserted-by":"crossref","first-page":"28324","DOI":"10.1074\/jbc.C113.495473","article-title":"Adipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages","volume":"288","author":"Chatterjee","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12944-018-0919-x","article-title":"Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation","volume":"17","author":"Khadir","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.11.004_b0110","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1210\/jc.2010-0148","article-title":"Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss","volume":"95","author":"Brix","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2478\/jbcr-2018-0002","article-title":"Fetuin-A\u2013Alpha2-Heremans-Schmid glycoprotein: from structure to a novel marker of chronic diseases Part 2. Fetuin-A\u2013A marker of insulin resistance and related chronic diseases","volume":"11","author":"Komsa-Penkova","year":"2018","journal-title":"J. Biomed. Clin. Res."},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0120","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1017\/S0007114515002639","article-title":"Association between dietary factors and plasma fetuin-A concentrations in the general population","volume":"114","author":"Nimptsch","year":"2015","journal-title":"Br. J. Nutr."},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0130","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41598-018-19677-4","article-title":"Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease","volume":"8","author":"Miura","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0135","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diacare.29.02.06.dc05-1484","article-title":"Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects","volume":"29","author":"Mori","year":"2006","journal-title":"Diabetes Care"},{"issue":"53","key":"10.1016\/j.clinbiochem.2020.11.004_b0140","doi-asserted-by":"crossref","first-page":"41827","DOI":"10.1074\/jbc.M110.128926","article-title":"Fetuin-A (\u03b12HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cells","volume":"285","author":"Sakwe","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0145","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/ijo.2014.203","article-title":"Fetuin-A: a novel link between obesity and related complications","volume":"39","author":"Trepanowski","year":"2015","journal-title":"Int. J. Obesity"},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5507\/bp.2015.018","article-title":"Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature","volume":"159","author":"Dabrowska","year":"2015","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"issue":"6","key":"10.1016\/j.clinbiochem.2020.11.004_b0155","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cellsig.2010.11.003","article-title":"The \u201cthrifty\u201d gene encoding Ahsg\/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistance","volume":"23","author":"Goustin","year":"2011","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.11.004_b0160","first-page":"1445","article-title":"Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level","volume":"7","author":"Srinivas","year":"1993","journal-title":"Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0165","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/ijms19082211","article-title":"Impact of Fetuin-A (AHSG) on tumor progression and type 2 diabetes","volume":"19","author":"Ochieng","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0170","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2337\/diabetes.54.8.2477","article-title":"A synonymous coding polymorphism in the \u03b12-Heremans-Schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians","volume":"54","author":"Siddiq","year":"2005","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.11.004_b0175","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s00125-004-1556-7","article-title":"\u03b1 2-Heremans\u2013Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action","volume":"47","author":"Dahlman","year":"2004","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40618-017-0697-8","article-title":"The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies","volume":"41","author":"Roshanzamir","year":"2018","journal-title":"J. Endocrinol. Invest."},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.11.004_b0185","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1007\/s00125-017-4385-1","article-title":"Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion","volume":"60","author":"Gerst","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0190","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"\u03b12-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan","year":"2006","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.clinbiochem.2020.11.004_b0195","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.105.588723","article-title":"Association between human fetuin-A and the metabolic syndrome data from the heart and soul study","volume":"113","author":"Ix","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.300.2.182","article-title":"Fetuin-A and incident diabetes mellitus in older persons","volume":"300","author":"Ix","year":"2008","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.clinbiochem.2020.11.004_b0205","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2337\/db08-0538","article-title":"Plasma fetuin-A levels and the risk of type 2 diabetes","volume":"57","author":"Stefan","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.01.007","article-title":"Effect of liraglutide therapy on serum fetuin A in patients with type 2 diabetes and non-alcoholic fatty liver disease","author":"Zhang","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0215","article-title":"Multiple biomarkers improved prediction for the risk of type 2 diabetes mellitus in Singapore chinese men and women","volume":"43","author":"Wang","year":"2019","journal-title":"Diabetes Metab. J."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2265.2011.04070.x","article-title":"Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes","volume":"75","author":"Ou","year":"2011","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2020.11.004_b0225","doi-asserted-by":"crossref","first-page":"925","DOI":"10.5551\/jat.3830","article-title":"Serum fetuin-A is an independent marker of insulin resistance in Japanese men","volume":"17","author":"Ishibashi","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"issue":"12","key":"10.1016\/j.clinbiochem.2020.11.004_b0230","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/dme.12539","article-title":"Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India","volume":"31","author":"Dutta","year":"2014","journal-title":"Diabet. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0235","doi-asserted-by":"crossref","DOI":"10.12669\/pjms.36.2.1106","article-title":"Association of fetuin-A with dyslipidemia and insulin resistance in type-II Diabetics of Pakistani population","volume":"36","author":"Fatima","year":"2020","journal-title":"Pak. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0240","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000802","article-title":"Effects of dynamic change in fetuin-A levels from the first to the second trimester on insulin resistance and gestational diabetes mellitus: a nested case\u2013control study","volume":"8","author":"Jin","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"6","key":"10.1016\/j.clinbiochem.2020.11.004_b0245","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.tjog.2019.09.015","article-title":"A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus","volume":"58","author":"Lu","year":"2019","journal-title":"Taiwan. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0250","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.atherosclerosis.2011.01.020","article-title":"Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese","volume":"216","author":"Xu","year":"2011","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.clinbiochem.2020.11.004_b0255","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.2042-7158.2012.01561.x","article-title":"Role of fetuin-A in atherosclerosis associated with diabetic patients","volume":"64","author":"Singh","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0260","unstructured":"World Health Organization. Obesity and overweight. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. (Accessed 09.04.2019)."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0265","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00261-012-9862-x","article-title":"Causes of obesity","volume":"37","author":"Wright","year":"2012","journal-title":"Abdom. Radiol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0029665100000380","article-title":"Body-weight regulation: causes of obesity","volume":"59","author":"Martinez","year":"2000","journal-title":"Proc. Nutr. Soc."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11373-008-9261-z","article-title":"Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond","volume":"15","author":"Lu","year":"2008","journal-title":"J. Biomed. Sci."},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0280","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011\u20132012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0285","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0290","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cen.12303","article-title":"Causal relationship between body mass index and fetuin-A level in the Asian population: a bidirectional mendelian randomization study","volume":"81","author":"Thakkinstian","year":"2014","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0295","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/cen.12076","article-title":"The effects of caloric restriction on F etuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial","volume":"79","author":"Choi","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2020.11.004_b0300","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.metabol.2014.02.006","article-title":"Circulating fetuin-A levels are not affected by short and long-term energy deprivation and\/or by leptin administration","volume":"63","author":"Hwang","year":"2014","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0305","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00592-017-1068-9","article-title":"Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"55","author":"Guo","year":"2018","journal-title":"Acta Diabetol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.11.004_b0310","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1249\/MSS.0000000000000338","article-title":"Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity","volume":"46","author":"Malin","year":"2014","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0315","article-title":"Alterations of serum Ser312-phosphorylated fetuin-A from exercise-induced moderate body weight loss in individuals with obesity","author":"Ren","year":"2019","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0320","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.1152\/ajpendo.00089.2018","article-title":"Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance","volume":"317","author":"Ren","year":"2019","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.11.004_b0325","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1210\/jc.2009-0916","article-title":"Fetuin-A and change in body composition in older persons","volume":"94","author":"Ix","year":"2009","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0330","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diabetes.51.8.2450","article-title":"Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene","volume":"51","author":"Mathews","year":"2002","journal-title":"Diabetes"},{"issue":"08","key":"10.1016\/j.clinbiochem.2020.11.004_b0335","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-0043-115904","article-title":"Effect of a 12-week aerobic exercise training on serum fetuin-A and adipocytokine levels in type 2 diabetes","volume":"126","author":"Zhang","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0340","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/dom.12918","article-title":"Effects of short-term energy restriction on liver lipid content and inflammatory status in severely obese adults: R esults of a randomized controlled trial using 2 dietary approaches","volume":"19","author":"Baldry","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0345","doi-asserted-by":"crossref","unstructured":"A. Babler, C. Schmitz, A. B\u00fcscher, M. Herrmann, F. Gremse, T.G. Gorgels, J. Floege, W. Jahnen-Dechent, Soft tissue calcification in mice is governed by fetuin-A, pyrophosphate and magnesium. bioRxiv 2019:577239.","DOI":"10.1101\/577239"},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tcm.2012.07.020","article-title":"Fetuin-A function in systemic mineral metabolism","volume":"22","author":"Herrmann","year":"2012","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0355","first-page":"1","article-title":"Association of AHSG gene polymorphisms with serum Fetuin-A levels in individuals with cardiovascular calcification in west of Iran","author":"Mohammadi-Noori","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"9360","key":"10.1016\/j.clinbiochem.2020.11.004_b0360","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228938","article-title":"Microvasculopathy and soft tissue calcification in mice are governed by fetuin-A, magnesium and pyrophosphate","volume":"15","author":"Babler","year":"2020","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0370","first-page":"605","article-title":"Cellular mechanisms of aortic valve calcification","volume":"5","author":"Leopold","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0375","series-title":"Advances in Clinical Chemistry","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.acc.2019.08.002","article-title":"Vascular and valvular calcification biomarkers","author":"Clemente","year":"2020"},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0380","doi-asserted-by":"crossref","unstructured":"M. Herrmann, A. Babler, I. Moshkova, F. Gremse, F. Kiessling, U. Kusebauch, V. Nelea, R. Kramann, R.L. Moritz, M.D. McKee, Microvasculopathy, luminal calcification and premature aging in fetuin-A deficient mice. bioRxiv 2019:577098.","DOI":"10.1101\/577098"},{"issue":"34","key":"10.1016\/j.clinbiochem.2020.11.004_b0385","doi-asserted-by":"crossref","first-page":"20789","DOI":"10.1074\/jbc.271.34.20789","article-title":"The serum protein \u03b12-HS glycoprotein\/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells a possible role in mineralization and calcium homeOSTASIS","volume":"271","author":"Schinke","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.clinbiochem.2020.11.004_b0390","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.M210868200","article-title":"Structural basis of calcification inhibition by \u03b12-HS glycoprotein\/fetuin-A formation of colloidal calciprotein particles","volume":"278","author":"Heiss","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0395","first-page":"193","article-title":"Systemic and local levels of fetuin-A in calcific aortic valve stenosis","volume":"20","author":"Kaden","year":"2007","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.11.004_b0400","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1681\/ASN.2005040365","article-title":"Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice","volume":"16","author":"Merx","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0405","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jdiacomp.2016.11.006","article-title":"Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus","volume":"31","author":"Eleftheriadou","year":"2017","journal-title":"J. Diabetes Complications"},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0410","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3889\/oamjms.2019.167","article-title":"High fetuin-A level as a protective factor to abdominal aortic calcification in Indonesian regular hemodialysis patients","volume":"7","author":"Muzasti","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0415","series-title":"Nephrology Dialysis Transplantation: 2017","article-title":"Fetuin-A levels in kidney transplant recipients with cardiac valvular calcification","author":"Koca","year":"2017"},{"issue":"24","key":"10.1016\/j.clinbiochem.2020.11.004_b0420","doi-asserted-by":"crossref","first-page":"14429","DOI":"10.1073\/pnas.95.24.14429","article-title":"Fetuin (\u03b12-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules","volume":"95","author":"Wang","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.clinbiochem.2020.11.004_b0425","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1681\/ASN.2004100895","article-title":"Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification","volume":"16","author":"Reynolds","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"22","key":"10.1016\/j.clinbiochem.2020.11.004_b0430","doi-asserted-by":"crossref","first-page":"12755","DOI":"10.1074\/jbc.271.22.12755","article-title":"Fetuin\/\u03b12-HS glycoprotein is a transforming growth factor-\u03b2 type II receptor mimic and cytokine antagonist","volume":"271","author":"Demetriou","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0435","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10157-005-0385-4","article-title":"Pathogenesis of vascular calcification in dialysis patients","volume":"9","author":"Ketteler","year":"2005","journal-title":"Clin. Exp. Nephrol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0440","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/ndt\/gfh891","article-title":"Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients","volume":"20","author":"Wang","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0445","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.mat.0000202606.44826.6b","article-title":"Cardiac calcifications: fetuin\u2013A and other risk factors in hemodialysis patients","volume":"52","author":"Coen","year":"2006","journal-title":"ASAIO J."},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0450","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/ndt\/gfl204","article-title":"Fetuin-A and kidney function in persons with coronary artery disease\u2014data from the Heart and Soul Study","volume":"21","author":"Ix","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0455","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4103\/1319-2442.239643","article-title":"Predictors of coronary calcification in Indian hemodialysis patients","volume":"29","author":"Jasani","year":"2018","journal-title":"Saudi J. Kidney Dis. Transplant."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0460","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/dmrr.299","article-title":"\u03b12-Heremans Schmid glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunction","volume":"18","author":"Ren","year":"2002","journal-title":"Diabetes\/Metab. Res. Rev."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0465","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MCA.0b013e32832fe5d5","article-title":"Fetuin-A is associated with calcified coronary artery disease","volume":"21","author":"Mori","year":"2010","journal-title":"Coron. Artery Dis."},{"issue":"10","key":"10.1016\/j.clinbiochem.2020.11.004_b0470","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1525-1594.2009.00814.x","article-title":"Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients","volume":"33","author":"Kirkpantur","year":"2009","journal-title":"Artif. Organs"},{"issue":"23","key":"10.1016\/j.clinbiochem.2020.11.004_b0475","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2011.08.035","article-title":"The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study","volume":"58","author":"Ix","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0480","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000491025","article-title":"Serum calcification propensity and fetuin-A: Biomarkers of cardiovascular disease in kidney transplant recipients","volume":"48","author":"Bostom","year":"2018","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0485","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0300060518814080","article-title":"Non-traditional risk factors for coronary calcification and its progression in patients with type 2 diabetes: The impact of postprandial glycemia and fetuin-A","volume":"47","author":"Krajnc","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0490","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2016.03.029","article-title":"Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis","volume":"248","author":"Aroner","year":"2016","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0495","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1523-1755.2005.00172.x","article-title":"Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification","volume":"67","author":"Mehrotra","year":"2005","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.clinbiochem.2020.11.004_b0500","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1291\/hypres.31.1163","article-title":"Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients","volume":"31","author":"Mikami","year":"2008","journal-title":"Hypertens. Res."},{"issue":"10","key":"10.1016\/j.clinbiochem.2020.11.004_b0505","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1373\/clinchem.2006.084947","article-title":"Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction","volume":"53","author":"Lim","year":"2007","journal-title":"Clin. Chem."},{"issue":"24","key":"10.1016\/j.clinbiochem.2020.11.004_b0510","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1161\/CIRCULATIONAHA.108.814418","article-title":"Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke","volume":"118","author":"Weikert","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0515","doi-asserted-by":"crossref","first-page":"C551","DOI":"10.1152\/ajpcell.1992.263.3.C551","article-title":"Fetuin: its enigmatic property of growth promotion","volume":"263","author":"Nie","year":"1992","journal-title":"Am. J. Physiol.-Cell Physiol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0520","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00408-004-2534-z","article-title":"Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts","volume":"183","author":"Hetzel","year":"2005","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0525","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jsscb.1981.380160409","article-title":"Effect of serum, fibronectin, and laminin on adhesion of rabbit intestinal epithelial cells in culture","volume":"16","author":"Burrill","year":"1981","journal-title":"J. Supramol. Struct. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0530","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1073\/pnas.44.1.4","article-title":"Molecular growth requirements of single mammalian cells: the action of fetuin in promoting cell attachment to glass","volume":"44","author":"Fisher","year":"1958","journal-title":"PNAS"},{"issue":"18","key":"10.1016\/j.clinbiochem.2020.11.004_b0535","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1158\/0008-5472.CAN-04-1117","article-title":"\u03b12HS-glycoprotein, an antagonist of transforming growth factor \u03b2 in vivo, inhibits intestinal tumor progression","volume":"64","author":"Swallow","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0540","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.2353\/ajpath.2010.100177","article-title":"Lack of fetuin-A (\u03b12-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-\u03b2 signaling pathway in a mouse model of breast cancer","volume":"177","author":"Guillory","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0545","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbamcr.2004.06.005","article-title":"Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A","volume":"1693","author":"Kundranda","year":"2004","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0550","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2013.07.125","article-title":"Fetuin-A (\u03b12HS-glycoprotein) is a serum chemo-attractant that also promotes invasion of tumor cells through Matrigel","volume":"438","author":"Nangami","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"17","key":"10.1016\/j.clinbiochem.2020.11.004_b0555","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1158\/1078-0432.CCR-10-3271","article-title":"Telomere attrition and decreased fetuin-A levels indicate accelerated biological aging and are implicated in the pathogenesis of colorectal cancer","volume":"17","author":"Maxwell","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0560","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2796.2007.01890.x","article-title":"Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients","volume":"263","author":"Carrero","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0565","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.2147\/OTT.S222426","article-title":"Roles of EAAT1, DHFR, and fetuin-A in the pathogenesis, progression and prognosis of chondrosarcoma","volume":"12","author":"He","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"8","key":"10.1016\/j.clinbiochem.2020.11.004_b0570","first-page":"9021","article-title":"Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma","volume":"8","author":"Tian","year":"2015","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"7","key":"10.1016\/j.clinbiochem.2020.11.004_b0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158789","article-title":"Relationship between fetuin A, vascular calcification and fracture risk in dialysis patients","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0580","first-page":"394","article-title":"Relationship between vitamin D receptor gene FokI and ApaI polymorphisms and serum levels of fetuin-A, vitamin D, and parathyroid hormone in patients on hemodialysis","volume":"8","author":"Ghorbanihaghjo","year":"2014","journal-title":"Iran. J. Kidney Dis."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0585","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3389\/fphys.2019.00966","article-title":"Circulating fetuin-A and risk of all-cause mortality in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"10","author":"Zhou","year":"2019","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0590","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000494665","article-title":"Coronary artery calcification in hemodialysis and peritoneal dialysis","volume":"48","author":"Jansz","year":"2018","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0595","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000095782","article-title":"Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients","volume":"26","author":"Cozzolino","year":"2006","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0600","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12882-016-0245-3","article-title":"Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients","volume":"17","author":"Lin","year":"2016","journal-title":"BMC Nephrol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0605","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ndt\/gfz222","article-title":"Dialysis initiation improves calcification propensity","volume":"35","author":"Ponte","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0610","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2369-14-122","article-title":"Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients","volume":"14","author":"Pateinakis","year":"2013","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0615","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11255-017-1740-6","article-title":"Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients","volume":"50","author":"Ulutas","year":"2018","journal-title":"Int. Urol. Nephrol."},{"issue":"23","key":"10.1016\/j.clinbiochem.2020.11.004_b0620","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.clinbiochem.2020.11.004_b0625","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0630","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.clinbiochem.2020.11.004_b0635","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"18","key":"10.1016\/j.clinbiochem.2020.11.004_b0640","doi-asserted-by":"crossref","first-page":"19169","DOI":"10.1074\/jbc.M307880200","article-title":"Evidence for a serum factor that initiates the re-calcification of demineralized bone","volume":"279","author":"Price","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.clinbiochem.2020.11.004_b0645","first-page":"799","article-title":"Relationship between fetuin-A, bone turnover and inflammatory markers concentrations in serum of maintenance hemodialyzed patients","volume":"73","author":"Fedak","year":"2016","journal-title":"Przegl. Lek."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0650","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/1744-9987.12194","article-title":"Effect of serum fibroblast growth factor-23, matrix Gla Protein and Fetuin-A in predicting osteoporosis in maintenance hemodialysis patients","volume":"18","author":"Wu","year":"2014","journal-title":"Ther. Apheresis Dial."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0655","first-page":"2182","article-title":"Association of serum fetuin-A levels with allograft outcome in renal transplant recipients","volume":"12","author":"Mehrsai","year":"2015","journal-title":"Urol. J."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0660","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.tp.0000251647.72673.c7","article-title":"Endothelial dysfunction and fetuin A levels before and after kidney transplantation","volume":"83","author":"Caglar","year":"2007","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.clinbiochem.2020.11.004_b0665","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/j.1523-1755.2005.00333.x","article-title":"Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0670","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ndt\/gfr382","article-title":"Serum fetuin-A and vitamin D in children with mild-to-severe chronic kidney disease: a cross-sectional study","volume":"27","author":"Schaible","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.clinbiochem.2020.11.004_b0675","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2215\/CJN.06150710","article-title":"Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients","volume":"6","author":"Mar\u00e9chal","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0680","series-title":"Transplantation Proceedings: 2015","first-page":"1398","article-title":"Association between cardiac valvular calcification and serum fetuin-A levels in renal transplant recipients","author":"Kocyigit","year":"2015"},{"issue":"10","key":"10.1016\/j.clinbiochem.2020.11.004_b0685","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s10157-019-01761-2","article-title":"The association between cardiac valvular calcification and fetuin-A levels in kidney transplant recipients","volume":"23","author":"Koca","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.clinbiochem.2020.11.004_b0690","series-title":"Transplantation Proceedings: 2015","first-page":"2703","article-title":"Serum fetuin a levels: are they a reliable marker for hepatic steatosis and regional adiposity in renal transplant recipients?","author":"Roshdy","year":"2015"},{"issue":"7","key":"10.1016\/j.clinbiochem.2020.11.004_b0695","article-title":"Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.clinbiochem.2020.11.004_b0700","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/iju.13187","article-title":"Pathophysiology-based treatment of urolithiasis","volume":"24","author":"Yasui","year":"2017","journal-title":"Int. J. Urol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0705","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-8529(02)00030-0","article-title":"Hyperoxaluric calcium nephrolithiasis","volume":"31","author":"Asplin","year":"2002","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0710","first-page":"394","article-title":"The relationship between serum and urinary Fetuin-A levels and kidney stone formation among kidney stone patients","volume":"70","author":"Mehrsai","year":"2017","journal-title":"Cent. Eur. J. Urol."},{"issue":"24","key":"10.1016\/j.clinbiochem.2020.11.004_b0715","doi-asserted-by":"crossref","first-page":"22144","DOI":"10.1074\/jbc.M300744200","article-title":"The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex","volume":"278","author":"Price","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0720","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbrc.2004.05.169","article-title":"In vitro hydroxyapatite adsorbed salivary proteins","volume":"320","author":"Vitorino","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.11.004_b0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016945","article-title":"A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.clinbiochem.2020.11.004_b0730","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1464-410X.2007.07432.x","article-title":"Urine fetuin-A values in relation to the presence of urolithiasis","volume":"101","author":"Stejskal","year":"2008","journal-title":"BJU Int."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0735","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/iju.IJU_340_16","article-title":"Urine and serum fetuin-A levels in patients with urolithiasis","volume":"33","author":"Arora","year":"2017","journal-title":"Indian J. Urol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0740","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.urology.2009.08.058","article-title":"Fetuin-A gene polymorphism in patients with calcium oxalate stone disease","volume":"75","author":"Aksoy","year":"2010","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.11.004_b0745","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4081\/aiua.2013.4.180","article-title":"Serum fetuin-A and recurrent urolithiasis in young adults","volume":"85","author":"Prezioso","year":"2013","journal-title":"Arch. Ital. Urol. Androl."},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.11.004_b0750","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00439-004-1222-7","article-title":"Association of \u03b12-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels","volume":"116","author":"Osawa","year":"2005","journal-title":"Hum. Genet."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202030881X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202030881X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:56:11Z","timestamp":1757865371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991202030881X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":150,"alternative-id":["S000991202030881X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.11.004","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of fetuin-A with diverse functions and multiple mechanisms on human health","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}